SPRC Stock Summary and Trading Ideas (Scisparc Ltd. - | NASDAQ:SPRC)

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Scisparc Ltd. - trades on the NASDAQ stock market under the symbol SPRC.

As of December 12, 2025, SPRC stock price declined to $1.84 with 140,750 million shares trading.

SPRC has a beta of 0.89, meaning it tends to be less sensitive to market movements. SPRC has a correlation of 0.01 to the broad based SPY ETF.

SPRC has a market cap of $6.03 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, SPRC traded as high as $726.17 and as low as $1.55.

SPRC has underperformed the market in the last year with a price return of -65.8% while the SPY ETF gained +14.0%. SPRC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +1.7% and -16.4%, respectively, while the SPY returned +4.0% and -0.2%, respectively.

SPRC support price is $1.71 and resistance is $2.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPRC shares will trade within this expected range on the day.